logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 2
  • 1
    Uhelak, Martin
    Born in March 1985
    Individual (7 offsprings)
    Officer
    2016-04-07 ~ now
    OF - Director → CIF 0
    Mr Martin Uhelak
    Born in March 1985
    Individual (7 offsprings)
    Person with significant control
    2017-03-31 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
  • 2
    Uhelakova, Kristina
    Director born in March 1987
    Individual (7 offsprings)
    Officer
    2016-06-23 ~ 2017-03-31
    OF - Director → CIF 0
parent relation
Company in focus

ALMA PHARMA LTD

Period: 2016-04-07 ~ now
Company number: 10109625
Registered name
ALMA PHARMA LTD - now
Standard Industrial Classification
86220 - Specialists Medical Practice Activities
Brief company account
Called-up share capital not yet paid and not classified as a current asset
0 GBP2025-03-31
0 GBP2024-03-31
Fixed Assets
400,594 GBP2025-03-31
242,170 GBP2024-03-31
Current Assets
338,438 GBP2025-03-31
384,744 GBP2024-03-31
Creditors
Amounts falling due within one year
-229,493 GBP2025-03-31
-226,110 GBP2024-03-31
Net Current Assets/Liabilities
108,945 GBP2025-03-31
158,634 GBP2024-03-31
Total Assets Less Current Liabilities
509,539 GBP2025-03-31
400,804 GBP2024-03-31
Creditors
Amounts falling due after one year
0 GBP2025-03-31
0 GBP2024-03-31
Net Assets/Liabilities
509,539 GBP2025-03-31
400,804 GBP2024-03-31
Equity
509,539 GBP2025-03-31
400,804 GBP2024-03-31
Average Number of Employees
12024-04-01 ~ 2025-03-31

Related profiles found in government register
  • ALMA PHARMA LTD
    Info
    Registered number 10109625
    Pavilion Pharmacy, Brighton Terrace, London SW9 8DJ
    PRIVATE LIMITED COMPANY incorporated on 2016-04-07 (10 years 1 month). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-04-01
    CIF 0
  • ALMA PHARMA LTD
    S
    Registered number missing
    Pavilion Pharmacy, Brighton Terrace, London, England, SW9 8DJ
    Private Limited Company
    CIF 1
  • ALMA PHARMA LTD
    S
    Registered number 10109625
    9, Brighton Terrace, Brixton, London, United Kingdom, SW9 8DJ
    Private Limited Company in Companies House, United Kingdom
    CIF 2
child relation
Offspring entities and appointments 2
  • 1
    HETHERINGTON GROUP HEALTHCARE LIMITED
    - now 02494218
    PLEAT LIMITED - 2019-07-17
    POSTPAUSE LIMITED - 1990-05-09
    9 Brighton Terrace, Brixton, London, England
    Active Corporate (7 parents)
    Person with significant control
    2022-08-02 ~ now
    CIF 1 - Ownership of voting rights - 75% or more OE
    CIF 1 - Ownership of shares – 75% or more OE
  • 2
    PHARMACY NEAR ME LTD
    16185106
    9 Brighton Terrace, Brixton, London, United Kingdom
    Active Corporate (3 parents, 1 offspring)
    Person with significant control
    2025-01-15 ~ now
    CIF 2 - Ownership of shares – 75% or more OE
    CIF 2 - Ownership of voting rights - 75% or more OE
    CIF 2 - Right to appoint or remove directors OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 5 April 2026 and licensed under the Open Government Licence v3.0.